EQUINOX NEPREMICNINE D.D. Financials EQUINOX NEPREMICNINE d.d.
Equities
EQNX
SI0031117813
Real Estate Development & Operations
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.5 EUR | -2.78% |
|
-2.78% | 0.00% |
| 2022 | An unknown buyer acquired an unknown minority stake in EQUINOX NEPREMICNINE d.d. from Axor holding d.d. | CI |
| 2022 | EQUINOX NEPREMICNINE d.d. has completed an IPO. | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 89.69 | 94.18 |
| Enterprise Value (EV) 1 | 93.48 | 99.41 |
| P/E ratio | 126 x | 108 x |
| Yield | - | - |
| Capitalization / Revenue | 12.2 x | 12.1 x |
| EV / Revenue | 12.7 x | 12.8 x |
| EV / EBITDA | 19.4 x | 24.1 x |
| EV / FCF | 26,119,612 x | 28,906,088 x |
| FCF Yield | 0% | 0% |
| Price to Book | 2.17 x | 2.36 x |
| Nbr of stocks (in thousands) | 1,794 | 1,794 |
| Reference price 2 | 50.00 | 52.50 |
| Announcement Date | 2/13/24 | 2/13/24 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 6.715 | 7.344 | 7.787 |
| EBITDA 1 | 3.956 | 4.813 | 4.131 |
| EBIT 1 | 0.5221 | 1.404 | 0.3673 |
| Operating Margin | 7.78% | 19.11% | 4.72% |
| Earnings before Tax (EBT) 1 | 0.3836 | 0.8496 | 0.971 |
| Net income 1 | 0.5399 | 0.712 | 0.8691 |
| Net margin | 8.04% | 9.69% | 11.16% |
| EPS 2 | 0.3010 | 0.3969 | 0.4845 |
| Free Cash Flow | - | 3.579 | 3.439 |
| FCF margin | - | 48.73% | 44.16% |
| FCF Conversion (EBITDA) | - | 74.36% | 83.26% |
| FCF Conversion (Net income) | - | 502.67% | 395.7% |
| Dividend per Share | - | - | - |
| Announcement Date | 4/15/22 | 2/13/24 | 2/13/24 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | 2.05 | 3.79 | 5.23 |
| Net Cash position 1 | - | - | - |
| Leverage (Debt/EBITDA) | 0.518 x | 0.787 x | 1.267 x |
| Free Cash Flow | - | 3.58 | 3.44 |
| ROE (net income / shareholders' equity) | - | 1.75% | 2.14% |
| ROA (Net income/ Total Assets) | - | 1.52% | 0.41% |
| Assets 1 | - | 46.69 | 214.5 |
| Book Value Per Share 2 | 22.30 | 23.00 | 22.20 |
| Cash Flow per Share 2 | 3.730 | 6.020 | 2.040 |
| Capex 1 | 0.23 | 0.16 | - |
| Capex / Sales | 3.5% | 2.2% | - |
| Announcement Date | 4/15/22 | 2/13/24 | 2/13/24 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 102M | |
| +10.00% | 28.11B | |
| -7.82% | 27.28B | |
| +25.23% | 26.41B | |
| +13.99% | 24.87B | |
| +43.67% | 22.93B | |
| +9.88% | 21.18B | |
| +0.63% | 19.18B | |
| +23.84% | 16.19B | |
| -10.20% | 15.82B |
- Stock Market
- Equities
- EQNX Stock
- Financials EQUINOX NEPREMICNINE d.d.